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CHAPTER 1 
INTRODUCTION 
Rheumatoid arthritis (RA) is a chronic autoimmune disorder that causes pain, 
inflammation and stiffness in joints, and fatigue, and often results in disability in its sufferers. 
This disease impacts approximately 1% of the general population and is three times more 
common in women than men (Anderson, Bradley, Young, McDaniel & Wise, 1985). 
Furthermore, although rheumatoid arthritis is typically treated through traditional medicine (e.g., 
disease modifying, biological response modifying, or anti-inflammatory medications), many 
patients still report symptoms of pain and fatigue.  
It is widely recognized that psychological factors have a relationship with physical health 
and may cause and/or worsen illness. Patients with rheumatoid arthritis reported that stress was 
the most common cause of a flare up and that interpersonal stress was related to their levels of 
pain (Keefe et al., 2002). Evidence has also shown that 13-15% of patients with RA have been 
diagnosed with major depressive disorder, which is approximately twice as prevalent as the 
normal population (Dickens, McGowan, Clark-Carter & Creed, 2002). Specifically, a link 
between RA and stress, coping, and depression has been found (Anderson et al. 1985; Dickens et 
al., 2002), suggesting that these psychological factors impact people with RA. These 
psychological factors likely not only result from having RA, but also appears to cause, trigger, 
exacerbate, or maintain pain and dysfunction among patients with RA.  
The role played by psychological factors in the onset and course of RA is further 
substantiated by evidence that psychological interventions improve the health of patients with 
RA.  Two psychological interventions that have been demonstrated to have some health benefits 
in RA are written emotional disclosure (WED) and pain coping skills training (CST).  
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Written Emotional Disclosure 
Written emotional disclosure (WED) is a technique that is used to improve patient’s 
emotional awareness and decrease pain, and has been examined in a number of studies. During 
WED, patients are asked to write about their most stressful or traumatic experience freely and 
openly and to discuss their thoughts and feelings about the event. Often patients are additionally 
instructed to write about ways in which they have coped with their stressors and to find meaning 
behind their stressor. Written emotional disclosure typically occurs in 3 to 4 sessions lasting 20-
30 minutes each. These sessions can occur in the laboratory or at the participant’s home. 
Early work on WED suggested that participants who did not share their stressful or 
traumatic experiences had worse health, more physical symptoms and higher health care 
utilization (Pennebaker, Barger, & Tiebout, 1989; Pennebaker & O’Heeron, 1984). Based on this 
early work, Pennebaker and Beall (1986) tested WED on healthy undergraduates. Results from 
this initial study found that participants who engaged in WED used less health care at follow-up.  
It is believed that WED is a useful technique because suppressing negative emotions and 
experiences can have a deleterious impact on health, and WED provides an outlet for people to 
express those emotions and experiences they normally withhold. Thus, the goal of WED is to 
reduce physical symptoms by allowing patients to express rather than suppress their emotions 
and cognitions, which may help them resolve stressors. Suppression of emotions may be 
particularly problematic in those with already comprised health, and those with chronic health 
problems often have barriers (e.g., lack of social support) that may limit their ability to express 
their thoughts and feelings. This suggests WED may be particularly beneficial to those with 
rheumatoid arthritis.  
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Since Pennebaker’s initial study, this technique has been extended to treat various 
populations, including chronic pain patients. Meta-analyses showed that patients with physical or 
psychological problems who engaged in WED had significant improvements on their physical 
and psychological well-being; however, the effect size was small (d = .19; Frisina, Borod, & 
Lepore 2004). It should also be noted that these effect sizes in individual studies ranged from d = 
-.24 to d = .49, suggesting substantial unexplained variability in outcomes.  
A number of studies have examined WED in patients with RA and have shown mixed 
results of the efficacy of this technique in improving outcomes. For example, one study 
examined 51 RA patients who wrote for 3 consecutive 20-minute sessions about their most 
stressful life event and found that WED improved disease activity at the 4-month follow-up 
(Smyth, Stone, Hurewitz, & Kaell, 1999). Lumley and colleagues (2011) examined WED in 88 
RA participants who wrote about a traumatic or stressful experience for 4, 20-minute sessions. 
Results showed that participants who engaged in WED had decreased pain at 1 and 6 months 
follow-up compared to participants who wrote about positive or neutral events; however this 
study showed no effects on various other measures. No main effects on disease activity, physical 
or psychological functioning were discovered in another study comparing the effects of enhanced 
written disclosure, time management writing, or an arthritis educational video in RA patients 
(Broderick, Stone, Smyth, & Kaell, 2004). Furthermore, in a study of verbal emotional 
disclosure in which RA patients spoke into a tape recorder about a traumatic event, Kelley and 
colleagues (1997) found less mood disturbance and improved physical functioning compared to 
the control condition but there were no treatment effects on joint condition or pain.  
Although there appears to be modest effects of WED on pain and physical functioning, 
there is evidence to suggest that improvements are made in a subset of these participants. For 
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example, Smyth and colleagues (1999) found that 47.1% of patients (which included their 
sample of asthma patients) had clinically relevant improvements. It should also be noted that 
48.6% of these participants had no change, while 4.3% got worse, indicating that WED is 
effective for only a subset of patients.  
Coping Skills Training 
Coping skills training, which is a form of cognitive-behavioral therapy, is aimed 
specifically to help patients with pain conditions, including RA, manage their pain and the 
psychological impact of their condition. Dixon and colleagues (2007) described CST as typically 
consisting of 3 phases. In the first phase, patients are educated about the biopsychosocial model 
of pain, which views pain as a result of, and maintained by, biologic or genetics factors, 
psychological traits or factors, and social issues such as support, culture and environment. The 
goal of this phase is to educate patients on the rationale for using psychological interventions to 
treat what many patients view as a physical disease. In the second phase of CST, patients are 
trained in various cognitive-behavioral techniques, such as progressive muscle relaxation 
training, pleasant activity scheduling, imagery, distraction and cognitive restructuring. This 
phase aims to give patients a battery of skills that can aid in managing their physical symptoms. 
The third and final phase involves teaching patients how to apply the skills they have learned to 
specific situations and problems that arise in their lives. Additionally, this phase teaches patients 
to recognize the antecedents and early signals to their pain so that they are able to implement 
these techniques early.  
Dixon and colleagues (2007) conducted a meta-analysis on the effectiveness of cognitive-
behavioral treatments, including CST, in patients with rheumatoid arthritis or osteoarthritis. 
Results from this meta-analysis of 15 studies showed a significant, albeit small, benefit of CBT 
5 
 
on pain and a moderate effect size benefit on joint swelling; however, no effects were found on 
fatigue or stiffness.  
Another meta-analysis of cognitive-behavioral therapies in RA patients found positive 
effects of these treatments on pain, and mixed findings regarding effects on disability and joint 
functioning (Astin, Beckner, Soeken, Hochberg, & Bernman, 2002). Of the nine studies 
examined in this meta-analysis, moderate to large effect sizes of CBT on reduced pain were 
found. Findings regarding the impact of CBT on joint dysfunction and disability were highly 
inconsistent, ranging from no significant effects to large effect sizes. 
It may be informative to examine in detail several of the original studies included in these 
meta-analyses. One study examined 55 RA patients who were receiving treatment in an 
outpatient clinic (Leibing, Pfingsten, Bartman, Rueger, & Schuessler, 1999). Participants were 
randomized to receive 12 weekly group CBT sessions or routine care. Results showed that 
participants who engaged in CBT compared to those who received routine care had 
improvements in a variety of measures including pain, depression, helplessness, and improved 
coping, which was defined as increased positive reappraisal and acceptance, and decreased 
resignation. Both pain and pain intensity were measured and there was on average a 28.8% 
reduction in pain and 17.5% average reduction of pain intensity after engaging in CBT. There 
were no effects from CBT on many objective measures of disease status including C-reactive 
protein (CRP), erythrocyte sedimentation rate (ESR), joint dysfunction, or grip strength.  
Sharpe and colleagues (2000) examined 53 RA patients who engaged in either 8, weekly 
individual CBT sessions or routine care. This study found that CBT decreased CRP, joint 
dysfunction, and depression; but it did not affect coping strategies, ESR, or subjective pain 
ratings. Results also showed that there was variability in how much improvement was made by 
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patients regarding swollen and painful joints. At post-treatment for the CBT group, 30% showed 
no change, 35% were defined as “improved,” and 17% were “much improved.” This pattern was 
maintained at follow-up with 48% showing no change, 22% with improvement and 26% with 
much improvement. These results demonstrate that some patients show large benefit from CBT, 
whereas others do not improve at all.   
Results from these studies suggest that CBT seems to have positive effects for RA 
patients, specifically in its ability to reduce pain. However there are mixed findings regarding its 
effectiveness on physical functioning and physiology. More importantly for the current study, 
these findings suggest that CBT is not uniformly effective for all patients. 
In summary, research has demonstrated small to moderate effect sizes of both WED and 
CST on improvements in patients with RA, and that only some people improve. Thus, it is 
important to determine which patients are most likely to benefit from each intervention. It is 
likely that certain psychological and social factors impact who improves the most from 
treatments and techniques such as WED and CST. Three such constructs that potentially 
moderate the effects of either WED and/or CST are alexithymia, social constraints, and self-
efficacy. These are examined in the current study.  
Alexithymia 
Alexithymia was first described by Sifneos (1973) in reference to a subgroup of patients 
who had psychosomatic disorders and were unresponsive to traditional insight-oriented 
psychotherapy. Alexithymia was defined as a patient’s inability to put their thoughts and feelings 
into words, a difficulty in describing and identifying their emotions, and an inclination to focus 
on external factors, such as physical symptoms (Bagby & Taylor, 1997). Apfel and Sifneos 
(1979) described a typical patient with alexithymia as presenting a multitude of physical 
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complaints, having an absence of fantasy or imagination, having trouble finding the appropriate 
words to describe their feelings, and often being passive-aggressive and rigid. Additionally, it 
has been found that people with alexithymia have an increased risk for developing health 
problems and for worsening their current symptoms (Lumley et al., 2008).  
Previous research of psychological interventions on patients with alexithymia focused 
largely on insight oriented or emotional processing, which could be the reason these studies 
showed little effectiveness since these are areas known to be troublesome in such patients. 
Research has shown that alexithymia predicted worse treatment outcomes in various conditions, 
such as alcoholism, gastrointestinal, depression and mixed psychiatric disorders (Lumley et al., 
2008), supporting the original observation by Sifneos.  
There is still reason to believe that people with alexithymia will benefit from certain 
psychological interventions or techniques, but perhaps not others. In particular, a cognitive 
behavioral approach, such as coping skills training, would likely be beneficial to people with 
alexithymia. Specifically, it would be useful for patients with alexithymia to be taught concrete 
skills, such as restructuring their cognitions and modifying their behaviors, and navigating social 
situations that they may normally find difficult.  
Positive outcomes with alexithymic patients who have engaged in cognitive behavioral 
treatments have been found. For example, alexithymic patients who received CBT were more 
likely to remain in smoking cessation groups (Lumley, Downy, Stettner, Wehmer, & Pomerleau, 
1994). Alexithymic patients were also more likely to have favorable outcomes in CBT aimed at 
patients who were undergoing treatment for substance use and in vitro fertilization (Kakatsaki et 
al., 2004).  
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Skills based approaches, like CBT, have shown to improve outcomes in people with 
alexithymia; however, improvements may not be seen in insight and emotion focused 
approaches, such as WED. People with alexithymia, by definition, have difficulty putting into 
words their thoughts and feelings, which is a key component of WED. There is evidence to 
suggest that individual differences in alexithymia and its facets may predict who improves from 
WED. One study examined 68 rheumatoid arthritis patients who completed a written emotional 
disclosure exercise about their thoughts and feelings about a traumatic life event (Lumley, 2004). 
Results from this study showed that higher levels of Difficulty Identifying Feelings, a subscale of 
the TAS-20, was significantly related to worse disability and joint impairment compared to 
participants who engaged in a time management writing exercise, compared to WED. In a 
similar study with 48 women with chronic pelvic pain, higher alexithymia was related to more 
pain in participants who engaged in the disclosure exercise, compared to the control writing 
condition (Lumley, 2004). Another study by Lumley (2004) suggested that in participants with 
migraine headaches, alexithymia predicted increased headache frequency and pain. Though these 
studies suggest that patients with alexithymia would not benefit from engaging in a disclosure 
exercise, several studies suggest that there are favorable outcomes from WED for those with 
alexithymia (Paez, Velasco, & Gonzalez, 1999; Solano, Donati, Pecci, Persichetti, & Colaci, 
2003).   
It is likely that alexithymia moderates the relationship between WED and health, but that 
the direction of that relationship differs based on the facets of alexithymia, which the current 
study seeks to explore further. Based on this evidence it is expected that alexithymia will be a 
moderator of both WED and CST.  
Social Constraints 
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Social constraints have been defined as the situations and perceptions of those situations 
that lead a person to feel misunderstood or unsupported by their social network, such as their 
family, friends and co-workers (Lepore & Revenson, 2007). Stemming from a social psychology 
perspective, researchers often suggested that these constraints arise from the thoughts, feelings 
and actions of other individuals (Lepore & Revenson, 2007). Frequently the consequences of 
these feelings lead people to inhibit or refrain from sharing their thoughts, feelings, and 
experiences with others. Recently this construct has been applied to the field of health 
psychology because of the increasing realization that individuals suffering from illness often 
having difficulty expressing their emotions surrounding their illness, and the concern that when 
emotional expression is impeded there may be a worsening of physical and psychological health.  
Indeed empirical evidence demonstrates that social constraints are often experienced by people 
with chronic or long-term illnesses and have deleterious effects on their psychological and 
physical functioning. In an early study of social constraints, Lepore and colleagues (1998) 
examined a sample of 177 men with prostate cancer. Results suggested that men who had more 
social constraints had worse mental health and more avoidance than men who had few social 
constraints. Techniques such as WED, which allow people to express themselves in private, may 
be particularly helpful for people with high levels of social constraints.  
Several studies have examined social constraints as a moderator of the effects of WED. 
One study of the effects of WED in 104 cancer patients had patients write about how cancer 
affected their lives for three, 20-minute sessions. At the 6-month follow-up, patients who had 
high baseline levels of social constraints had less distress after engaging in WED than those with 
low levels of social constraints (Zakowski, Herzer, Barret, Milligan, & Beckman, 2004). These 
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results illustrate that social constraints may have a moderating effect on WED, such that 
engaging WED may buffer the negative impact of social constraints.  
Current research on the role of social constraints has not focused on rheumatoid arthritis. 
However, because many people experience social constraints, it is likely that patients with RA 
also have these experiences. Thus, it is reasonable to hypothesize that RA patients with elevated 
social constraints would benefit from WED.  
Self-efficacy 
Self-efficacy is another psychological construct that likely plays a role in who improves 
from psychological interventions. Bandura (1982), who pioneered work in self-efficacy, defined 
this construct as a person’s belief that he or she has the ability to control or change a difficult 
situation. In the same vein, he suggested that self-efficacy is the confidence a person has within 
himself or herself to successfully accomplish something. This definition implies that self-
efficacy has to do with people’s judgments of how well they will deal with the event, not how 
well they will actually deal with the event. It is likely that improvements from psychological 
interventions often occur in people with high amounts of self-efficacy because those with high 
self-efficacy often exert more effort than those with low self-efficacy (Bandura, 1982).  
A substantial body of literature suggests people with high self-efficacy have less physical 
and psychological impairments than those with low self-efficacy. One example of this was 
demonstrated in research conducted by Schiaffino and Revenson (1995) on patients with RA. 
This study showed that in participants who had low self-efficacy there were higher levels of 
depression than participants who had high self-efficacy; however, they did not examine the 
effects of self-efficacy as a moderator of pain or physical functioning.  
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Indeed very little research has been conducted on how self-efficacy moderates the 
outcomes of psychological interventions. One study that did examine relationship found that in 
participants with migraine headaches, lower self-efficacy was significantly related to 
improvements from relaxation training and WED compared to their respective control groups 
(Kraft, Lumley, D’Souza, & Dooley, 2008). This result is opposite of what would be expected as 
another body of literature on mental health, which can be extended to self-efficacy, has shown 
that participants who begin treatment with better mental health have better treatment outcomes. 
For example, Barron (1953) showed patients entering treatment with better mental health had 
better mental health when their treatment concluded than those who entered treatment with 
worse mental health. It is likely then that self-efficacy does moderate treatment outcomes from 
WED; however, the directionality is unclear at this point. As there has been no evidence to the 
contrary, it is, also, hypothesized that people entering treatment with higher self-efficacy will 
have better health outcomes from CST 
Overall these findings suggest that psychological interventions and techniques have some 
beneficial outcomes for patients with RA, but that these improvements do not seem to be seen 
equally across all patients. This prompts the question, which patients with RA show 
improvements in pain and physical functioning from these interventions? It is likely that this 
answer lies in psychological variables such as alexithymia, social constraints, and self-efficacy.  
Goals of this study 
The goal of this study was to examine which patients with rheumatoid arthritis improve 
from engaging in CST or WED, compared with control conditions. Alexithymia, social 
constraints, and self-efficacy were examined as potential moderators of health outcomes of CST 
and WED. Data for this study were gathered from a recently completed randomized controlled 
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trial examining the effects of CST and WED on physical and psychological functioning in 
patients with RA. This thesis conducted analyses on these data to determine moderators of the 
effects of these two interventions, relative to their control conditions. 
Hypotheses 
This study examined three hypotheses regarding the impact of the three potential 
moderators on health outcomes of CST and WED.  
1) It was hypothesized that alexithymia would moderate the effects of health outcomes 
on CST and on WED.  
a. It was hypothesized that those high in alexithymia would have greater health 
improvements from CST compared to a control condition, Arthritis Education. 
b. It was hypothesized that those high in alexithymia would have poorer 
outcomes after WED compared with a control writing condition, Health 
Behavior writing. 
c. For both of the above hypotheses, the three facets or subscales were examined 
separately as potential moderators, because research suggests that they may 
not all predict outcomes uniformly, or in the same direction. 
2) It was hypothesized that social constraints would moderate the effects of health 
outcomes on WED, such that those high in social constraints would have greater 
improvements in health outcomes following WED compared to Health Behavior 
writing. No specific hypotheses are made about the potential moderation of social 
constraints on the effects of CST. 
3) It was hypothesized that self-efficacy would moderate the effects of health outcomes 
on CST, such that those high in self-efficacy would have greater improvements in 
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health outcomes from CST compared to Arthritis Education.  No specific hypotheses 
are made about the potential moderation of self-efficacy on the effects of WED. 
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CHAPTER 2 
METHOD 
Participants 
From March, 2005 to November, 2007 we recruited and randomized to intervention 
conditions a total of 264 adults who met the 1987 American College of Rheumatology’s criteria 
for a diagnosis of rheumatoid arthritis from hospitals and clinics in the metropolitan areas of 
Detroit, Michigan and Durham, North Carolina. Participants were 81.1% female and had an 
average age of 55 years old and had an RA diagnosis for an average of 15.65 years. Additionally, 
participants were 67.8% Caucasian, 28% African American, 1.5% Asian, and 2.3% other. 
Participants were excluded from the study if they a) had another disorder that would 
significantly affect function (e.g., lupus, COPD, CHF, cancer); b) had cognitive impairment 
(dementia, retardation, psychosis) or illiteracy; c) were currently in psychotherapy or a formal 
behavioral pain management program; d) were physically unable to walk (walking aides were 
acceptable) or write; or e) had RA for less than two years. Participants were not asked to change 
their current medications or treatments for RA to be included in this study.  
Procedures 
Recruitment occurred at Wayne State University / Detroit Medical Center and Duke 
Medical Center. During the initial visit written informed consent was obtained, and participants 
went through a medical examination during which they were screened for inclusion criteria and 
verification of a diagnosis of RA by a rheumatologist. Additionally, participants completed a 
series of measures including those to assess alexithymia and social constraints. Participants who 
remained eligible were asked to return 30 days later for their baseline visit to complete physical 
and mental health questionnaires to assess pain severity, physical and psychological functioning, 
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as well as self-efficacy. They were also asked to get a blood draw at a nearby clinic to assay C-
reactive protein (CRP) within a week of completing questionnaires.  
After the baseline session participants were randomized into a 2 x 2 factorial design to 
receive a written condition (WED or control writing) and an educational condition (CST or 
education control. For the current study, participants were examined to compare written 
emotional disclosure to neutral control writing about health behaviors and coping skills training 
to arthritis education. After randomization, participants received their instructions for their 
writing and education groups. Next, they scheduled times to complete their first writing session 
and all 8 of their weekly treatment sessions. Participants completed their first writing session in 
the laboratory and the remaining 3 writing sessions at home. Participants returned 1, 4 and 12 
months after completing the intervention for follow-up questionnaires, a physical examination 
with the rheumatologist, and a CRP blood draw. Participants were given monetary compensation 
for completing the evaluation and for the blood draw.  
Written Emotional Disclosure 
The WED technique was modeled after Pennebaker’s research and occurred over 4 
sessions, 20 minutes in length, over the course of 1 week. Participants were instructed to write 
about one particular stressful experience that continued to affect them, as described more fully 
below. They were encouraged to write freely and openly about their thoughts and emotions. 
Session 1. Participants were asked first to identify a stressful or traumatic experience that 
still causes them distress. They were asked to pick an event that they try to avoid thinking about 
and that they are not comfortable discussing with other people. Next, they were asked to think 
about that particular event and to recall their memories of it as vividly as possible. Then they 
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were instructed to write about the facts about the experience, and their innermost thoughts and 
feelings.  
Session 2. In this session, participants were instructed to first re-read their prior writing. 
Next, they were asked to continue writing about that particular experience, their emotions, and 
thoughts about that stressful event. Participants were also told that if they thought of a more 
difficult or traumatic topic that they may begin to write about that during this session.  
Session 3. Participants reviewed their previous writing and continued writing about their 
most traumatic experience. Participants were asked to try to find meaning from their stressful 
experience and how it had possibly changed their views, beliefs or their health. Specifically, they 
were asked to focus on how this event has affected their RA. In addition, they were asked to 
write about anything they have learned from the experience or any new insights they had gained.  
Session 4. In the final session participants were asked to write about how they have coped 
with their stressful experience or feelings in the past. They were asked to discuss whether they 
found their coping strategies useful or not, and how they plan to cope with this problem or their 
feelings in future. Participants were asked to brainstorm new coping strategies and how they 
believed they could implement them into their life. 
Health Behavior Writing  
Health behavior writing occurred in the same format as WED, but participants were 
instructed to writing about various health related topics, as described more fully below, as 
opposed to writing about stressful topics. Participants were instructed in this condition to write 
only about the facts and events and not to include their feelings and opinions. This served as the 
control condition for WED.  
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Session 1. During the first session participants were instructed to write about how they 
spent and managed their time during the past week.  
Session 2. In this session participants were asked to write about their eating habits. They 
were told to start writing about what they had eaten on the current day and work their way 
backwards for each day until their time had run up 
Session 3. Participants were told to write about the kinds and how much physical activity 
they had engaged in during the past week. They were also instructed to write about any times 
that they had not engaged in exercise or physical activities.  
Session 4. In the final session, participants were instructed to write about their sleeping 
habits over the past week. They were told to write what time they went to sleep, how many hours 
they slept, if they woke up in the night and if they were able to fall back asleep. Participants were 
told to focus on the characteristics of their sleep.  
Coping Skills Training 
The eight, 1-hour long CST sessions were given by a trained therapist (graduate student 
or post-doc in clinical psychology) and were based on cognitive-behavioral techniques that have 
demonstrated effectiveness for chronic pain problems. The overarching goal of CST was to 
provide patients skills to manage their pain and other symptoms.  The eight sessions were as 
follows: 
Session 1. Therapists explained the theory of CST and the gate-control theory of pain, so 
that participants had an understanding that pain and stress are interconnected. Participants also 
learned progressive muscle relaxation.    
Session 2. This session focused on teaching participants how to increase pleasurable 
activities to reduce or combat their pain and discomfort. Therapists discussed the benefits of 
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activity pacing; that is, taking frequent breaks or spreading out an activity to avoid overexertion 
and potential flare-ups. Participants and therapists brainstormed ways to engage in pleasant 
activities. Participants were instructed to continue using relaxation techniques at home.  
Session 3. Training in communication skills and assertiveness began during the third 
session. Specifically, participants learned how to ask for and turn down requests, and how to give 
positive and negative feedback in relationships. Therapists taught these skills using role playing, 
modeling, and by giving feedback. Participants also learned in this session how to engage in 
mini-relaxation, through which they learned how to relax in 30-60 seconds.  
Session 4. In this session, communication skills were revisited and cognitive restructuring 
was introduced. Participants were taught cognitive techniques to help them identify the 
relationships between their thoughts, feelings and behaviors. Cognitive restructuring was used to 
teach participants how to rephrase their maladaptive thoughts with positive coping thoughts.  
Session 5. This session focused on recognizing automatic thinking and in particular 
automatic maladaptive thoughts. Participants practiced identifying these thoughts and positively 
reframing them. In addition, participants learned about using activity-rest cycles to prevent 
themselves from overexertion that can lead to increased pain.  
Session 6. Participants continued to learn how to change negative thinking and reviewed 
the activity-rest cycle. They also learned about distraction techniques for pain and relaxation 
techniques that be easily done anywhere, quickly.   
Session 7. This session began by reviewing all of the coping skills participants were 
taught. The majority of the session focused on using coping skills to solve problems in the 
participants’ lives. With their therapist they identified problems and brainstormed which coping 
techniques would work best to solve the issue.  
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Session 8. During the final session, the main goal was to address relapse prevention by 
having participants write a maintenance plan that included coping skills to deal with anticipated 
setbacks and pain.  
Arthritis Education 
The eight, 1-hour arthritis education sessions were directed by a health educator and 
served as the control condition against CST. These sessions focused on the etiologies, symptoms 
and treatment options for RA and will be described in detail below.  
Session 1. This session focused on basic disease characteristics of RA such as possible 
etiologies, information about joint anatomy, and how RA specifically affects joints.  
Session 2. In this session reviewed information about joints and symptoms RA patients 
often feel in their joints, such as swelling and stiffness. This session also taught participants 
about other RA symptoms, in addition to joints, such as fatigue or muscle aches.  
Session 3. Participants learned about diagnosing RA, possible courses of the disease, and 
kinds of treatments. Focus was specifically on the various ways of treating RA (e.g. medications, 
nutrition, and exercise) and what the general goals of treatment are (e.g. remission, pain 
reduction).  
Session 4. During this session, participants learned briefly about the immune system and 
its relation to RA. The focus of this session was on specific types of medications and therapies 
used to treat RA, such as steroids and biologic response modifiers, and how the medications 
suppress the effects of RA.  
Session 5. In this session participants were taught about pain and the differences between 
acute and chronic pain. Participants also continued to learn about pain medications such as 
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analgesics (e.g. Tylenol, Excedrin) or non-steroidal anti-inflammatory drugs (e.g. Motrin) that 
are often used in treating RA.  
Session 6. Participants learned about complementary and alternative treatments for RA. 
Homeopathy, chiropractic medicine, acupuncture, massage therapy and biofeedback were 
discussed as treatments often used for RA patients. Additionally, dietary supplements (e.g. 
vitamins), nutrition, and exercise were discussed.  
Session 7. In this session, participants learned about surgeries, physical and occupational 
therapy and adaptive devices (e.g. jar openers, grooming aids, canes) that are used to treat RA. 
Benefits and risks of each were discussed.  
Session 8. During the last session, the educator discussed with the participant the benefits 
of being educated about their RA. They also discussed the importance of self-managing their 
disease with the treatments discussed in previous sessions and about sharing responsibility of 
their treatment with their physician. Participants also learned how to find more information on 
their own through websites and other resources.  
Measures 
Potential Moderator Measures 
Toronto Alexithymia Scale – 20 (TAS-20; Bagby, Parker, & Taylor, 1994). The TAS-20 
is a widely used scale that measures alexithymia. This 20-item scale assesses overall alexithymia 
and the three facets or subscales: Difficulty Identifying Feelings (e.g. “I am often confused about 
what emotion I am feeling”), Difficulty Describing Feelings (e.g. “I find it hard to describe how I 
feel about people”), and Externally Oriented Thinking (e.g. “I prefer to just let things happen 
rather than to understand why they turned out that way”). All items are rated on a scale of 1 
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(“strongly disagree”) to 5 (“strongly agree”), with higher scores indicating higher levels of 
alexithymia. Total scores and subscale scores were examined.  
General Social Constraints Scale (Lepore & Ituarte, 1999). This 15-item scale is used to 
rate how often participants feel that they must conceal, avoid, or minimize the problems they 
have surrounding their chronic illness to their family and friends (e.g. “How often in the past 
month did they change the subject when you tried to discuss your problems?”). Additionally, 
they were asked to report how supported they feel when they do disclose this information to their 
family and friends (e.g. “How often in the past month did you get the idea that they didn’t want 
to hear about your problems?”). All items are rated on a scale of 1 (“never”) to 4 (“often”). Items 
are then averaged together for a total score in which higher scores indicate more social 
constraints.  
Arthritis Self-efficacy Scale (ASE; Lorig, Chastain, Ung, Shoor, & Holman, 1989). This 
is a 20-item self-report scale used to measure self-efficacy specifically related to RA. 
Participants were asked to report how certain they are that they can perform specific tasks (e.g. 
“How certain are you that you can turn on outdoor faucet all the way on and all the way off?”), 
manage their RA pain (e.g. “how certain are you that you can keep arthritis pain from interfering 
with your sleep?”), and manage other RA symptoms (e.g. “how certain are you that you can deal 
with the frustration of arthritis?”). Each item is rated on a scale of 1 (“very uncertain”) to 10 
(“very certain”), with higher scores indicating higher levels of self-efficacy. 
Health Outcome Measures 
Arthritis Impact Measurement Scales -2, Pain and Physical Functioning Subscales 
(AIMS-2; Meenan, Mason, Anderson, Guccione, & Kazis, 1992). Both subscales consist of items 
on the AIMS-2 that are rated on a scale of 1 (“all days”) to 5 (“no days”), such that higher scores 
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indicate higher levels of either pain or physical functioning. The pain subscale consists of 5 items 
and measures the amount of self-reported pain experienced in the past month (e.g. “How often 
did you have pain in 2 or more joints at the same time?”) and stiffness (e.g. “How often did you 
have stiffness that lasted more than 1 hour from the time you woke up?”) due to RA. The 
physical functioning subscale, which consists of 28 items, is used to indicate levels of physical 
functioning on a variety of areas, such as mobility (e.g. “How often were you able to do errands 
in the neighborhood”), ability to walk and bend (e.g. “How many days did you have trouble 
bending, lifting and stooping?”), and ability to engage in self-care tasks (e.g. “You needed help 
to take a bath or shower.”).  
McGill Pain Questionnaire (MPQ; Melzack, 1975). The McGill Pain Questionnaire is a 
widely used scale that uses ratings of 20 categories with words describing various dimensions of 
pain and one question asking participants to rate the pain that they have experienced in the past 
week. Participants were asked to circle each word that describes their pain. For the current study, 
the present pain, sensory pain, and affective pain subscales were used. The present pain subscale 
of the MPQ is a widely used one item, self-reported measure of pain the participant has been 
experiencing in the past week. This item is rated on a scale of 1 (“no pain”) to 6 (“excruciating”).  
The sensory pain subscale consists of 10 word categories (e.g. “pulsing,” “aching.”), and the 
affective pain subscale consists of 5 categories (e.g. “punishing,” “suffocating.”).    
C-reactive protein (CRP). CRP is widely used to measure inflammation and disease 
status in patients with RA. Participants’ blood samples were assayed to measure mg/L of CRP, 
with higher levels of CRP indicating more inflammation and worse disease status. 
Swollen Joints. Measures of amount of swollen joints currently being experienced by 
each participant were gathered as part of a physical examination by a rheumatologist. The 
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rheumotologist noted whether each joint was swollen or not, and a total number of swollen joints 
was calculated from this report. Joints examined included phalanges (fingers), metacarpal 
phalanges (hands), wrists, elbows, shoulders, and knees on both the right and left side. 
Participants can receive a swollen joint count from 0 to 28, with higher scores indicating more 
swollen joints.  
Data analyses 
Data were entered into and analyzed using SPSS 19.0. Data were examined for potential 
outliers and skewed distributions. Both swollen joints and C-reactive protein had skewed 
distributions, so to normalize them, the swollen joints variable was transformed using a square 
root transformation, and C-reactive protein was transformed using a log transformation.  
Analyses of outcomes were conducted on the entire randomized sample; that is, intent to 
treat analyses of moderators was conducted.  Missing outcome values were replaced by the last 
value was carried forward technique, which meant using the baseline value for those participants 
who discontinued the study before providing any follow-up data. Intent to treat analyses was 
used to prevent any bias from occurring by using only participants who had completed the 
treatment.  
Next, to test the hypotheses, moderator analyses were conducted using hierarchical linear 
regressions, predicting residualized outcomes. Unstandardized residualized variables were 
created for each of the outcome variables at each follow-up period (1 month, 4 month, and 12 
month) by covarying its baseline value, using the entire sample. Moderator variables were then 
centered, and interaction terms were created between each moderator variable and group 
variable. Hierarchical regression analyses were set-up with unstandardized residual health 
outcomes predicting the interaction term, while covarying for moderator and group. This was 
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done to test for potential moderators of CST compared to Arthritis Education, and WED 
compared to Health Behavior writing separately. When significant interactions were found, it 
was concluded that there was a moderator relationship.  
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CHAPTER 3 
RESULTS 
Alexithymia as a Moderator  
Written Emotional Disclosure vs. Control Writing (Health Behavior Writing) 
To test the hypothesis that participants with higher alexithymia would have poorer health 
outcomes after WED compared to the control writing condition, the interactions between writing 
group and alexithymia (total and each subscale) in predicting outcome residual scores in a 
regression model were examined. In general this hypothesis was supported; participants with 
higher alexithymia had more swollen joints and worse physical functioning after WED compared 
to control writing. 
Specifically, total alexithymia marginally interacted with writing condition in predicting 
swollen joints 12 months later, t(259) = -1.90, p = .06,  = -0.37. Higher alexithymia tended to 
predict increased swollen joints in participants who engaged in WED ( = .12, p = .18), but 
decreases in swollen joints for the control writing group ( = -.12, p = .18). This finding appears 
to be driven by the difficulty identifying feelings subscale of the TAS-20, which significantly 
interacted with writing group in predicting swollen joints 12 months later, t(259) = -2.68, p = 
.008,  = -.51. Again, higher difficulty identifying feelings tended to predict increased swollen 
joints in participants who engaged in WED ( = .13, p = .14), but decreases in swollen joints for 
the control writing group ( = -.20, p = .02). Further, difficulty identifying feelings marginally 
interacted with writing condition in predicting physical functioning 1 month later, t(259) = 1.69, 
p = .09,  = .32. Higher difficulty identifying feelings tended to predict decreases in physical 
functioning in participants who engaged in WED ( = -.11, p = .22), but increases in physical 
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functioning for the control writing group ( = .10, p = .25). See Table 1 for the remaining 
moderator effects of alexithymia on WED vs. HBW on health outcomes. 
Coping Skills Training vs. Control Group (Arthritis Education)  
To test the hypothesis that participants with higher alexithymia would have greater health 
improvements from Coping Skills Training compared to the control group, Arthritis Education, 
the interactions between training condition and alexithymia (total and each subscale) in 
predicting residual outcome scores in a regression model were examined. In general, results 
suggested the opposite of this hypothesis; participants higher in alexithymia tended to have 
worse outcomes after engaging in CST compared to the control group. 
Specifically, total alexithymia significantly interacted with training condition in 
predicting C-reactive protein 1 month later, t(252) = -2.21, p = .03,  = -.44 and 4 months later, 
t(252) = -2.77, p = .006,  = -.54. At both time points, greater alexithymia tended to predict 
increased levels of CRP in the CST condition (1-month:  = .12, p = .18; 4-month:  = .14, p = 
.12), but decreased levels of CRP in the control group (1-month:  = -.16, p = .07; 4-month:  = -
.21, p = .02). This finding was largely driven by the difficulty identifying feelings subscale, 
which significantly interacted with training condition in predicting CRP 1 month later, t(252) = -
2.49, p = .01,  = -.49, and 4 months later, t(252) = -2.70, p = .008,  = -.53. Again, higher 
difficulty identifying feelings tended to predict increased levels of CRP in participants who 
completed the CST condition (1-month:  = .18, p = .05; 4-month:  = .20, p = .03), but 
decreased levels of CRP in the control condition (1-month:  = -.13, p = .13; 4-month:  = -.14, 
p = .13). Externally oriented thinking, a subscale of alexithymia, also significantly interacted 
with training condition to predict C-reactive protein, t(252) = -2.46, p = .01,  = -.49, such that 
higher externally oriented thinking tended to predict increases in CRP in participants who 
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engaged in the CST condition ( = .05, p = .57 ), but decreases in CRP in the control condition 
( = -.15, p =.09). Externally oriented thinking significantly interacted with training condition to 
predict sensory pain 1 month later, t(259) = -3.09, p = .002,  = -.59. Higher externally oriented 
thinking predicted increased sensory pain in participants who engaged in the CST condition ( = 
.16, p = .06), but decreases in sensory pain in the control condition ( = -.21, p = .01). Externally 
oriented thinking significantly interacted with training condition to predict affective pain 1 
month later, t(259) = -2.65, p = .009,  = -.51 and 12 months later, t(259) = -2.55, p = .01,  = -
.49. At both time points, higher externally oriented thinking predicted increased affective pain in 
participants who engaged in the CST condition (1-month:  =.18, p =.05, 12-month:  = .23, p = 
.007), but decreases in affective pain in the control condition (1-month:  = -.15, p = .08; 12-
month:  = -.09, p = .28). Difficulty identifying feelings also marginally interacted with training 
condition in predicting pain, on the AIMS-2 pain subscale, 4 months later, t(259) = 1.95, p = .05, 
 =.38. Inconsistent with the findings on CRP, higher alexithymia on the DIF subscale tended to 
predict decreased pain in participants who engaged in the CST condition ( = -.11, p = .23), but 
increases in pain in the control condition ( = .13, p = .13). See Table 1 for the remaining 
moderator effects of alexithymia on CST vs. AE on health outcomes. 
Social Constraints as a Moderator  
Written Emotional Disclosure vs. Control Writing (Health Behavior Writing) 
To test the hypothesis that participants with higher social constraints would have 
improved health outcomes from WED compared to control writing, the interactions between 
writing group and social constraints in predicting outcome residuals scores in a regression model 
were examined. In general, findings were limited but consistent with this hypothesis.  
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Social constraints significantly interacted with writing in predicting pain, measured by 
the AIMS-2, 4 months later, t(259) = -2.63, p = .009,  = -.52. Higher social constraints 
predicted increased pain in participants who engaged in WED ( = .26, p = .002), but social 
constraints were unrelated to pain in the control writing group ( = -.05, p = .61). See Table 2 for 
the remaining moderator effects of social constraints on WED vs. control writing on health 
outcomes. 
Coping Skills Training vs. Control Group (Arthritis Education)  
To test the hypothesis that social constraints would predict health improvements from 
Coping Skills Training compared to the control group, interactions between training condition 
and social constraints in predicting residual outcome scores in a regression model were 
examined. Findings were limited, but consistent with the hypothesis.  
Social constraints significantly interacted with training condition in predicting sensory 
pain 1 month later, t(259) = 2.02, p = .04,  = .40. In this model, social constraints were 
unrelated to sensory pain for participants who engaged in the CST condition ( = -.03, p = .74), 
but greater social constraints predicted more sensory pain in the control condition ( = .22, p = 
.01). See Table 2 for the remaining moderator effects of social constraints on CST vs. AE on 
health outcomes. 
Self-efficacy as a Moderator 
Written Emotional Disclosure vs. Control Writing (Health Behavior Writing) 
To test the hypothesis that self-efficacy would predict health improvements in WED 
compared to control writing, the interactions between writing group and self-efficacy in 
predicting residual outcome scores in a regression model were examined. In general, findings 
were limited and inconsistent.  
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Self-efficacy significantly interacted with writing in predicting sensory pain 4 months 
later, t(260) = 2.87, p = .004,  = .56. Higher self-efficacy predicted decreased sensory pain after 
participants engaged in WED ( = -.29, p = .001), and was unrelated to sensory pain in the 
control writing group ( = .05, p = .55). Self-efficacy also significantly interacted with writing in 
predicting swollen joints 1 month later, t(260) = -2.10, p = .04,  = -.42, and 4 months later, 
t(260) = -2.16, p = .03,  = -.43. In this model, self-efficacy was unrelated to swollen joints in 
WED at 1 month ( = .09, p = .28), but predicted decreased swollen joints in the control writing 
group ( = -.16, p = .07). At 4 months, higher self-efficacy predicted increased swollen joints in 
WED ( = .16, p = .06), but predicted decreased swollen joints in the control writing group ( = -
.10, p = .26). See Table 3 for the remaining moderator effects of self-efficacy on WED vs. 
control writing on health outcomes. 
Coping Skills Training vs. Control Group (Arthritis Education)  
To test the hypothesis that self-efficacy would predict health improvements in CST 
compared to control condition, AE, the interactions between training condition and self-efficacy 
in predicting residual outcome scores in a regression model were examined. Results were 
consistent across follow-up periods, but only for one outcome. Self-efficacy significantly 
interacted with training condition to predict CRP 1 month later, t(253) = 2.12, p = .04,  = .41, 
and 4 months later, t(253) = 2.22, p = .03,  = .43, and marginally interacted with training 
condition to predict CRP 12 months later, t(253) = 1.86, p = .07,  = .36. Greater self-efficacy 
predicted improved CRP after the CST condition (1-month:  = -.26, p = .004; 4-month:  = -
.26, p = .003; 12-month:  = -.29, p = .001), and was unrelated to CRP in the control condition 
(1-month:  = .00, p =.10; 4-month:  = .01, p = .90; 12-month:  = -.06, p = .51). See Table 3 
for the remaining moderator effects of self-efficacy on CST vs. AE on health outcomes. 
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CHAPTER 4 
DISCUSSION 
Psychological interventions for patients with chronic pain conditions have small to 
moderate effect sizes in improving pain and physical functioning (Astin et al., 2002; Dixon et al., 
2007; Frisina et al., 2004), and only a subset of patients with chronic pain improves from such 
psychological treatments. Accordingly, it is important to identify which patients with chronic 
pain benefit from psychological treatments. The goal of the current study was to examine if 
psychological and social factors predict health improvements from two psychological 
interventions. Specifically, alexithymia, social constraints, and self-efficacy were examined to 
see how they might differentially predict improvements in health from written emotional 
disclosure and coping skills training. Findings from this study suggest that, in general, 
alexithymia, social constraints, and self-efficacy inconsistently predict which patients will 
benefit from the psychological interventions. It appears that these factors may not be important 
predictors of which patients will benefit from the interventions in the current study.  
Alexithymia as a Moderator of WED vs. Control Writing 
Results for the first hypothesis showed inconsistent findings. Specifically, participants 
with higher alexithymia and difficulty identifying feelings had an increase in swollen joints after 
engaging in written emotional disclosure. Further, those with higher alexithymia and difficulty 
identifying feelings had decreased swollen joints after engaging in the control writing condition. 
But one finding was not consistent with this pattern. Participants with higher difficulty 
identifying feelings had improvements in physical functioning after engaging in written 
emotional disclosure, whereas participants higher in difficulty identifying feelings showed a 
decline in physical functioning after control writing.  
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The finding that those higher in alexithymia and difficulty identifying feelings had worse 
swollen joints after engaging in written emotional disclosure is consistent with Lumley’s (2004) 
findings, in which participants with various chronic health conditions (rheumatoid arthritis, 
chronic pelvic pain and headaches) who were higher in alexithymia had worse health outcomes 
after engaging in written emotional disclosure compared to a control condition. This pattern 
appears to be the most robust among those who are higher on the difficulty identifying feelings 
facet of alexithymia, suggesting that this facet is of particular importance in determining who 
will benefit from written emotional disclosure. This is not an altogether novel finding, as 
previous literature has shown that alexithymia predicted worse outcomes from insight-oriented 
treatments that are similar to written emotional disclosure (Sifneos, 1973). It is also important to 
note that in this sample, participants who were higher in alexithymia showed health benefits 
from engaging in the control writing condition, health behavior writing. This may have occurred 
because individuals with alexithymia are more likely to show more improvements when they are 
given concrete tasks, such as those in the health behavior writing condition (Lumley et al., 2008). 
This finding suggests that when given insight-oriented treatments (i.e., written emotional 
disclosure), rheumatoid arthritis patients with higher alexithymia tend to have worse health 
outcomes, whereas when they are given concrete and behaviorally oriented treatments (i.e., 
health behavior writing) they tend to have improvements in health.  
Opposite to the above findings, results showed that participants who were higher in 
difficulty identifying feelings had improvements in physical functioning after engaging in 
written emotional disclosure, whereas they had declines in physical functioning after engaging in 
the control writing condition. This finding is not consistent with previous literature (e.g., Lumley 
et al., 2004), and it is unclear how this finding should be interpreted. 
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These inconsistent findings suggest that it is still unclear how alexithymia moderates the 
effects of writing techniques (i.e., WED vs. HBW) on health outcomes. For some health 
outcomes participants higher in alexithymia had more improvements from written emotional 
disclosure than from the control writing group; however the opposite was also true for other 
health outcomes.  
Alexithymia as a Moderator of CST vs. Control Group (AE) 
The hypothesis that participants with higher alexithymia would have greater health 
improvements from coping skills training compared to the control condition was not supported, 
and findings were generally opposite than expected. Specifically, participants with higher 
alexithymia had less health improvement from coping skills training compared to the control 
condition, arthritis education. Participants who were higher in global alexithymia, difficulty 
identifying feelings, or externally oriented thinking had increased C-reactive protein, suggestive 
of more inflammation, after engaging in coping skills training; however, these participants 
showed decreases in C-reactive protein after engaging in arthritis education, the control 
condition. Additionally, participants higher in externally oriented thinking had increases in 
sensory and affective pain after engaging in coping skills training, but again showed decreases in 
sensory and affective pain after engaging in arthritis education. Conversely, participants who 
were higher on alexithymia and difficulty identifying feelings showed decreases in pain, after 
engaging in coping skills training, but increases in pain after engaging in the control condition.  
Unlike previous research, which found positive effects of CBT on health problems such 
as smoking cessation, substance use, and in vitro fertilization for individuals who have high 
alexithymia, results from the current study suggest that these findings may not extend to patients 
with chronic illness. One possible explanation for these findings could be that for those 
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individuals who are higher in alexithymia, it might be more difficult to engage in coping skills 
training, because the version of CST used in this study had a substantial focus on exploring 
thoughts and feelings, and engaging in these processes are more difficult for those who are 
higher in alexithymia.  
Again, it appears that the moderating relationship of alexithymia on coping skills training 
is inconsistent. These conflicting results suggest that the results on of the moderating effects of 
alexithymia on coping skills training, compared to arthritis education, and physical health may 
need to be interpreted with caution.  
Social Constraints as a Moderator of WED vs. Control Writing 
The second hypothesis, that participants with higher social constraints would have 
improved health from written emotional disclosure compared to the control writing condition, 
was not supported. Indeed, there was only one moderator relationship identified, and it was 
opposite to that hypothesized.  Participants with more social constraints had increases in pain 
after engaging in written emotional disclosure compared to the control writing condition about 
health behaviors, which was unrelated to levels of pain in participants high in social constraints.  
If this finding is reliable, it is not consistent with prior, but limited, research on the 
moderating effects of social constraints. The moderating effects of social constraints on 
outcomes from psychological interventions has been examined only on mental health variables 
as outcomes, and has not examined how those effects would apply to physical health. This study 
was unique in that it did examine the effects of social constraints on physical health and pain 
after a psychological treatment. Prior research by Zakowski and colleagues (2004) found that 
those with higher social constraints had improvements in distress after engaging in written 
emotional disclosure compared to a control treatment, but this finding could not be extrapolated 
34 
 
to the current study on physical health. Findings from the current study suggested that the 
opposite is true for health outcomes; those high in social constraints had worse health outcomes 
from written emotional disclosure compared to control writing. Zakowski and colleagues (2004) 
suggested that their findings could be due to a buffering effect that social constraints has on 
psychological outcomes, and it could be that the opposite is true for physical health. It is possible 
that people with more social constraints have an exacerbation of symptoms when they are asked 
to write about their most traumatic experience because they are unable to discuss that situation 
with members of their support group or are invalidated when they do try to discuss their 
traumatic experience, thereby worsening their pain. This explanation is parallel to Cohen’s 
(1998) theory of the buffering model of social support. This model indicates that social support 
includes two components: appraisal support, or someone to discuss your problems with, and self-
esteem support, or a person or relationship that makes you feel better about yourself. Written 
emotional disclosure allows individuals to receive a variation on appraisal support, but does not 
offer self-esteem support. The lack of self-esteem support, both in the treatment condition and in 
the lives of individuals with higher social constraints, may impede improvements in their 
physical health.  
Additionally, findings on the moderating effects of social constraints were limited and 
could have resulted from capitalization on chance. As such, the findings should be interpreted 
with caution. These results were limited to only one outcome measure and one time-point for 
each treatment comparison (WED vs. HBW). Further, the result that participants with more 
social constraints had increases in pain after engaging in written emotional disclosure compared 
to the control writing condition was not supported by other similar outcome measures that were 
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included in this study (e.g., MPQ Affective Pain, AIMS-2 Pain). As such, this finding should be 
interpreted with caution.  
Social Constraints as a Moderator of CST vs. Control Group (AE) 
The current study also explored how social constraints might predict health outcomes 
differently in coping skills training compared to the control condition. Findings were limited, and 
only one moderating relationship of social constraints was found. Results suggested that those 
who were higher in social constraints had more sensory pain after engaging in arthritis education, 
the control condition, whereas higher social constraints were unrelated to sensory pain after 
coping skills training. If this finding is reliable, these results might suggest that coping skills 
training may work by preventing pain from worsening for those with social constraints, but that 
it does not decrease pain for these individuals.  
It is also important to note that this is the first study of its kind to examine how social 
constraints may moderate the effects of various psychological treatments on health outcomes, 
and results from this study provide only minimal support that social constraints are an important 
factor in predicting which rheumatoid arthritis patients improve from psychological treatments.  
Self-efficacy as a Moderator of WED vs. Control Writing 
This study also explored how self-efficacy might predict improvements in written 
emotional disclosure compared to control writing. Findings were generally inconsistent and 
limited. More specifically, results from this study suggest that those with higher self-efficacy had 
improved sensory pain after engaging in written emotional disclosure compared to the control 
writing. In contrast, those who were lower in self-efficacy generally had improved swollen joints 
from written emotional disclosure compared to the control writing condition.  
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Although no specific hypotheses were made about how self-efficacy might moderate the 
health outcomes from the writing conditions, it might be expected, based on Bandura’s (1982) 
theory of self-efficacy that more health improvements would be seen in individuals who were 
higher in self-efficacy at the beginning of treatment (Schiaffino & Revenson, 1995). One finding 
from this study was supportive of this theory. This result found that those who were higher in 
self-efficacy had improved pain after written emotional disclosure compared to the control 
writing group.  
On the other hand, previous research has suggested that more health improvements would 
be seen in individuals who were lower in self-efficacy at the beginning of treatment. For 
example, results from Kraft and colleagues (2008) found that participants who were lower in 
self-efficacy had more improvements from written emotional disclosure compared to the control 
writing group. One finding from the current study is consistent with this previous research. This 
finding suggested that for those lower in self-efficacy, there were improvement in swollen joints 
after engaging in the written emotional disclosure group compared to the control writing group.  
It is also important to note that these results are contradictory. Results showed that higher 
self-efficacy predicted less sensory pain, but more swollen joints after participants engaged in 
written emotional disclosure compared to control writing. One possible explanation for these 
inconsistencies could be that the participants are rating their health as more improved than the 
rheumatologists.  
Due to the inconsistent and limited nature of the results, findings from the current study 
do not clearly illuminate the moderating effects of self-efficacy. It appears that that self-efficacy 
may not be an important predictor of which patients have health improvements after engaging in 
written emotional disclosure compared to the control writing group.   
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Self-efficacy as a Moderator of CST vs. Control Group (AE) 
The hypothesis, that higher self-efficacy would predict health improvements from coping 
skills training compared to the control condition, was supported, but only on one outcome, C-
reactive protein. Findings suggest that those who have higher self-efficacy had decreases in 
inflammation after engaging in coping skills training, but were unrelated to inflammation after 
engaging in the control condition. Further, this result was consistent at 1-month, 4-month and 12-
month follow-ups, suggesting it is a robust finding. This result is parallel to the literature on 
mental health, which suggests that those who enter treatment with better mental health (e.g., 
higher self-efficacy) will have better outcomes from treatment (Barron, 1953). It is important to 
note, however, that this result was only found on one outcome measure, so it is possible that this 
finding is specific to inflammation only and does not generalize to overall improved physical 
health. Further, this result may need to be interpreted with caution, as this result was not found 
for swollen joints, a similar objective measure of inflammation.  
Limitations 
One limitation of the study is that only a few psychological moderators were examined. It 
may be that other factors, such as coping style or readiness to change, predict which patients 
improve from these treatments. Additionally, demographics, such as, race, gender, and age, and 
disease characteristics (e.g. duration of diagnosis, disease severity) may also play an important 
role in which patients improve from these treatments.  
Additionally, the data could have been analyzed differently. This study chose to examine 
how certain factors might moderate improvements from written emotional disclosure and coping 
skills training as two distinct treatments. As such, analyzes were conducted separately to 
compare written emotional disclosure and coping skills training to their respective control 
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groups. However, participants were randomized to receive a component of each treatment arm, 
so they received one of the writing conditions as well as one of the class conditions. It is possible 
that there were synergistic effects of having both written emotional disclosure and coping skills 
training, or any combination of the treatments and control groups, which were missed by 
conducting the moderator analyses in such a way that kept them as independent groups. 
However, analyses of the various combined interventions would have yielded very small sample 
sizes to detect moderators. 
Another limitation of this study is that it applies only to the specific treatments used in 
this study (i.e., WED and CST). It could be the case that the moderators examined in the current 
study are important for other types of interventions, such as those that are insight-oriented or 
more purely behaviorally focused. Furthermore, results may have varied in this study if the 
interventions had been conducted in a different manner. For example, coping skills training 
could have been conducted in a group format, or participants could have kept their writings 
private or received feedback for them in the written emotional disclosure group. In a similar 
vein, findings from this study may apply only to individuals who have rheumatoid arthritis, and 
cannot be applied, at this point, to other patients with chronic pain or other illnesses.  
Additionally, participants may have had a difficult time fully engaging in written 
emotional disclosure. Many participants appeared to write about topics that were only mildly 
distressing, or they did not appropriately follow instructions and instead wrote about living with 
rheumatoid arthritis as a stressor. The lack of complete engagement by participants could have 
decreased the effectiveness of this intervention. Further, the writing control condition, health 
behavior writing, may have too closely mimicked an active intervention. In the control condition 
participants were asked to write about time management, eating, exercise, and sleeping habits. 
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Previous research has shown that by self-monitoring, the target behavior is likely to change, 
which is similar to the task that these “control” participants were given (Kumanyika et al., 2009). 
It is likely that participants saw improvements and changes in their pain, health, and functioning 
as a result of this control condition, which would have constrained the likelihood of finding 
moderating effects.   
Future Directions  
It will be important for future studies to examine other possible moderators of written 
emotional disclosure and coping skills training, so that individuals with rheumatoid arthritis can 
have the most suitable treatments offered to them, matched to their individual differences. It is 
possible that personality and demographic factors as well as other psychological constructs (e.g. 
coping style, readiness to change) are important indicators of who may improve from 
psychological treatments, and these should be examined as well. Future research should also 
examine if and how these findings might generalize to other chronic pain conditions, such as, 
fibromyalgia, low back pain or migraine headaches, or if the results are unique and specific to 
patients with rheumatoid arthritis.  
Future studies would benefit from having a wait-list or no treatment control group in 
addition to an active control condition, such as the arthritis education and health behavior writing 
groups that were included in this study. Having a wait-list or no treatment control group would 
help to further elucidate some of the inconsistent findings from this study. It will be important to 
know how patients with rheumatoid arthritis change over time without any treatment, and how 
those changes compare to an active control condition, as well as the treatment group. If the 
control groups in the study indeed are too similar to the active interventions, which might 
particularly be the case with written emotional disclosure and its control condition, then having 
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an inactive control group may more easily illuminate moderator effects that would otherwise be 
hidden.  
Implications 
The findings from this study indicate that written emotional disclosure and coping skills 
training may not work differently for individuals based on various psychological and social 
factors, at least those examined in this study. In particular, this study has shown that individuals 
with rheumatoid arthritis do not respond differently to these treatments based on levels of 
alexithymia, social constraints, and self-efficacy. However, there may be other moderator 
variables that would be important in illuminating which patients with rheumatoid arthritis 
improve from written emotional disclosure and coping skills training. Previous research has 
found that cognitive-behavior treatments and emotional disclosure have only small to moderate 
effect sizes, and that only a minority of patients shows improvements. Thus, it is likely that there 
are some psychological, social and/or personality variables that are important in determining 
which patients improve from these interventions. However, detecting these moderators might 
necessitate the development of better theory and a detailed analysis of components and 
requirements of these interventions. The search for these moderators is an important one and 
should continue.  
On the other hand, the focus may need to be shifted towards strengthening the 
interventions so that they can be more effective, and placing less focus on finding the individual 
differences that account for which patients improve from these interventions. Barlow and 
colleagues (2004) have suggested a similar concept, in which they propose that treatment 
research should focus on identifying what the most powerful components of treatments are, 
rather than examining individual differences that are predictive of treatment outcomes. In this 
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model they proposed that there are three factors that are three key components: 1) identifying 
antecedent cognitive reappraisals; 2) preventing emotional avoidance; and 3) facilitating action 
tendencies not associated with the emotion that is dysregulated. These authors argue that this 
approach will yield the most treatment gains, while cutting across various interventions, 
theoretical orientations, and—importantly—individual differences. Perhaps then, as Barlow and 
colleagues suggest, the real goal is to strengthen treatments, rather than tailoring them to 
individuals, particularly because the latter appears to be a difficult and complex task, as 
evidenced by the inconsistent and limited findings of the current study.  
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Table 1. Alexithymia as a moderator of the effects of WED vs. HBW and in CST vs. AE on health 
outcomes* 
 WED 
N = 135 
HBW 
N = 127 
CST 
N = 129 
AE 
N = 133 
AIM-2 Pain     
1 month follow-up .03 
(.00, .00, .08) 
-.06 
(-.12, -.05, .05) 
-.01 
(-.05, -.02, .05) 
-.01 
(-.04, -.04, .07) 
 
4 month follow-up .05 
(.03, .02, .06) 
.00 
(-.04, -.01, .07) 
-.09 
(-.11c, -.09, .00) 
.13 
(.13d, .07, .12) 
 
12 month follow-up .02 
(.09, -.06, -.01) 
-.09 
(-.06, -.12, -.04) 
-.09 
(-.03, -.15, -.07) 
.03 
(.09, -.05, .00) 
 
AIM-2 Physical functioning     
1 month follow-up -.08 
(-.11a, -.06, .00) 
.04 
(.10b, .02, -.04) 
.01 
(-.05, .03, .08) 
-.03 
(.04, -.03, -.10) 
 
4 month follow-up -.01 
(-.01, -.05, .03) 
.10 
(.05, .03, .05) 
-.01 
(-.05, -.07, .12) 
.09 
(.17, .06, -.04) 
 
12 month follow-up -.04 
(-.01, -.08, -.01) 
-.12 
(-.04, -.18, -.08) 
-.14 
(-.10, -.20, -.06) 
.00 
(.06, -.05, -.03) 
 
MPQ Sensory Pain     
1 month follow-up .01 
(.03, .07, -.09) 
-.02 
(.01, -.08, .02) 
.09 
(.03, .05, .16c) 
-.08 
(.03, -.05, -.21d) 
 
4 month follow-up -.06 
(.09, -.09, -.17) 
-.06 
(-.08, -.10, .04) 
-.09 
(-.05, -.16, -.02) 
-.04 
(.04, -.03, -.12) 
 
12 month follow-up .01 
(.04, .08, -.12) 
.01 
(.00, -.07, .09) 
.07 
(.02, .02, .15) 
-.04 
(.05, .00, -.17) 
MPQ Affective Pain     
1 month follow-up .02 
(.05, -.05, .04) 
-.01 
(.08, -.06, -.05) 
.12 
(.12, .01, .18c) 
-.07 
(.03, -.09, -.15d) 
 
4 month follow-up .04 
(.10, -.04, .00) 
.06 
(.09, .00, .05) 
-.01 
(.04, -.10, .04) 
.11 
(.16, .06, .02) 
 
12 month follow-up .15 
(.22, .06, .05) 
.10 
(.13, .05, .06) 
.24 
(.25, .12, .23c) 
.04 
(.15, .01, -.09d) 
 
C-reactive protein     
1 month follow-up -.03 
(-.04, -.06, .04) 
-.01 
(.09, .00, -.14) 
.12c 
(.18c, .05, .05) 
-.16d 
(-.13d, -.10, -.15) 
 
4 month follow-up .00 
(.03, -.08, .05) 
-.07 
(.03, -.09, -.16) 
.14c 
(.20c, .01, .11c) 
-.21d 
(-.14d, -.17, -.20d) 
 
12 month follow-up -.04 
(.04, -.14, -.01) 
-.01 
(.12, -.05, -.14) 
.04 
(.14c, -.10, .01) 
-.08 
(.01d, -.09, -.15) 
 
Swollen joints     
1 month follow-up -.05 -.03 -.04 -.03 
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(-.10, -.07, .07) (-.17, .03, .11) (-.14, .02, .05) (-.15, -.03, .13) 
 
4 month follow-up .05 
(-.01, .05, .10) 
.06 
(-.05, .12, .11) 
.00 
(-.06, .03, .04) 
.12 
(.00, .13, .16) 
 
12 month follow-up .12a 
(.13a, .06, .09) 
-.12b 
(-.20b, -.10, .03) 
.00 
(-.04, -.02, .08) 
.02 
(-.01, .00, .05) 
 
 
Note: *The value on the first line is the standardized beta, relating the TAS-20 total score to the 
residualized outcomes. The values in the parentheses are for the TAS-20 subscales: Difficulty Identifying 
Feelings, Difficulty Describing Feelings, and Externally Oriented Thinking, respectively. Standardized beta 
values with different subscripts are significantly different from one another, as determined by hierarchical 
regressions predicting health outcomes from an interaction of group by alexithymia. 
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Table 2. Social constraints as a moderator of the effects of WED vs. HBW and in CST vs. AE on health 
outcomes* 
 WED 
N = 135 
HBW 
N = 127 
CST 
N = 129 
AE 
N = 133 
AIM-2 Pain     
1 month follow-up .14 -.10 -.07 .09 
 
4 month follow-up .26a -.05b .02 .16 
 
12 month follow-up .16 -.02 -.03 .12 
 
AIM-2 Physical functioning     
1 month follow-up .20 -.01 .07 .12 
 
4 month follow-up .17 .05 .15 .06 
 
12 month follow-up .15 -.03 .03 .08 
 
MPQ Sensory Pain     
1 month follow-up .16 .06 -.03c .22d 
 
4 month follow-up .19 .08 .05 
 
.21 
 
12 month follow-up .20 .16 .11 .23 
 
MPQ Affective Pain     
1 month follow-up .14 .04 .10 .08 
 
4 month follow-up .12 
 
.12 
 
.12 .12 
12 month follow-up .10 .18 .07 
 
.19 
 
C-reactive protein     
1 month follow-up .09 -.06 -.05 .06 
 
4 month follow-up .09 -.07 .03 -.01 
 
12 month follow-up -.04 -.01 .04 -.08 
 
Swollen joints     
1 month follow-up -.18 -.12 -.08 -.18 
 
4 month follow-up -.22 -.06 -.16 
 
-.12 
 
12 month follow-up -.20 -.11 -.04 -.24 
 
 
Note: *The value on the first line is the standardized beta, relating the GSC total score to the residualized 
outcomes. Standardized beta values with different subscripts are significantly different from one another, 
as determined by hierarchical regressions predicting health outcomes from an interaction of group by 
social constraints. 
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Table 3. Self-efficacy as a moderator of the effects of WED vs. HBW and in CST vs. AE on health 
outcomes* 
 WED 
N = 135 
HBW 
N = 127 
CST 
N = 129 
AE 
N = 133 
AIM-2 Pain     
1 month follow-up -.17 -.06 -.05 -.20 
 
4 month follow-up -.23 -.09 -.08 -.24 
 
12 month follow-up -.14 .00 .00 -.15 
 
AIM-2 Physical functioning     
1 month follow-up -.02 -.21 -.09 -.17 
 
4 month follow-up -.05 -.20 -.10 -.15 
 
12 month follow-up -.05 -.09 -.03 -.12 
 
MPQ Sensory Pain     
1 month follow-up -.22 -.11 -.16 -.18 
 
4 month follow-up -.29a .05b -.13 
 
-.09 
 
12 month follow-up -.22 -.06 -.23 -.08 
 
MPQ Affective Pain     
1 month follow-up -.17 -.13 -.20 -.12 
 
4 month follow-up -.20 
 
-.06 
 
-.06 -.20 
12 month follow-up -.15 -.09 -.16 
 
-.11 
 
C-reactive protein     
1 month follow-up -.11 -.15 -.26c .00d 
 
4 month follow-up -.14 -.11 .26c .01d 
 
12 month follow-up -.16 -.17 -.29c .06d 
 
Swollen joints     
1 month follow-up .09a -.16b -.05 -.04 
 
4 month follow-up .16a -.10b .00 
 
.06 
 
12 month follow-up .09 .03 .05 .06 
 
 
Note: *The value on the first line is the standardized beta, relating the ASE total score to the residualized 
outcomes. Standardized beta values with different subscripts are significantly different from one another, 
as determined by hierarchical regressions predicting health outcomes from an interaction of group by self-
efficacy.  
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ABSTRACT 
ALEXITHYMIA, SOCIAL CONSTRAINTS, AND SELF-EFFICACY AS 
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Rheumatoid arthritis (RA) causes pain, disability, and inflammation. Written emotional 
disclosure (WED) and pain coping skills training (CST) improves adjustment, but effect sizes are 
small to moderate; research needs to identify patients most likely to benefit from WED and CST. 
A moderator analyses was conducted to determine if alexithymia, social constraints, or self-
efficacy predicted health outcomes from interventions at 1-, 4-, and 12-month follow-up. Health 
assessed at baseline and at each follow-up. Patients were randomized to WED or equivalent 
control (Health Behavior Writing), and to CST or equivalent control (Arthritis Education). 
Findings from this study suggest that alexithymia and social constraints inconsistently predict 
which patients will benefit from the psychological interventions, and that self-efficacy is has 
consistent but limited moderating effects on the interventions. In general, it appears that these 
factors may not be important predictors of which patients will benefit from the psychological 
interventions in the current study.  
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